Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
104,986,330
-
Number of holders
-
1,192
-
Total 13F shares, excl. options
-
89,209,869
-
Shares change
-
-2,558,432
-
Total reported value, excl. options
-
$46,858,212,368
-
Value change
-
-$1,426,702,234
-
Put/Call ratio
-
86%
-
Number of buys
-
564
-
Number of sells
-
674
-
Price
-
$525.00
Institutional Holders of REGENERON PHARMACEUTICALS, INC. - COMMON STOCK (REGN) as of Q2 2025
As of 30 Jun 2025 REGENERON PHARMACEUTICALS, INC. - COMMON STOCK (REGN) had 1,483 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 89,209,869 shares of stock of the company.
Largest 10 holders included VANGUARD GROUP INC, BlackRock, Inc., STATE STREET CORP, JPMORGAN CHASE & CO, Dodge & Cox, FMR LLC, Capital International Investors, GEODE CAPITAL MANAGEMENT, LLC, FRANKLIN RESOURCES INC, and Capital World Investors.
This table shows 1,483 institutional shareholders of the security as of 30 Jun 2025.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.